Literature DB >> 23155180

Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics.

Sébastien Savard1, Olivier Steichen, Arshid Azarine, Michel Azizi, Xavier Jeunemaitre, Pierre-François Plouin.   

Abstract

BACKGROUND: Initially based on histology, the diagnosis of renal artery fibromuscular dysplasia (FMD) is now based mostly on angiographic appearance because arterial tissue samples are rarely available. This retrospective cross-sectional study aimed to assess the clinical relevance of a binary angiographic classification of FMD lesions (unifocal or multifocal) based on computed tomographic or magnetic resonance angiography. METHODS AND
RESULTS: Adult patients diagnosed with FMD in a single tertiary care center for hypertension management were identified by screening of electronic files. FMD lesions were reviewed and classified according to computed tomography or magnetic resonance angiography as multifocal if there were at least 2 stenoses in the same arterial segment; otherwise, they were classified as unifocal. Of 337 patients with established renal artery FMD, 276 (82%) were classified as multifocal. Patients with unifocal and multifocal lesions differed significantly in median age at diagnosis of FMD (30 and 49 years) and hypertension (26 and 40 years), sex distribution (female:male ratio, 2:1 and 5:1), initial blood pressure (157/97 and 146/88 mm Hg), current smoking (50% and 26%), prevalence of unilateral renal artery lesions (79% and 38%), presence of kidney asymmetry (33% and 10%), renal revascularization procedures (90% and 35%), and hypertension cure rates in patients who underwent revascularization (54% and 26%).
CONCLUSIONS: A binary angiographic classification into unifocal or multifocal renal artery FMD is straightforward and discriminates 2 groups of patients with different clinical phenotypes.

Entities:  

Mesh:

Year:  2012        PMID: 23155180     DOI: 10.1161/CIRCULATIONAHA.112.117499

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  22 in total

1.  A plasma proteogenomic signature for fibromuscular dysplasia.

Authors:  Jeffrey W Olin; Antonio F Di Narzo; Valentina d'Escamard; Daniella Kadian-Dodov; Haoxiang Cheng; Adrien Georges; Annette King; Allison Thomas; Temo Barwari; Katherine C Michelis; Rihab Bouchareb; Emir Bander; Anelechi Anyanwu; Paul Stelzer; Farzan Filsoufi; Sander Florman; Mete Civelek; Stephanie Debette; Xavier Jeunemaitre; Johan L M Björkegren; Manuel Mayr; Nabila Bouatia-Naji; Ke Hao; Jason C Kovacic
Journal:  Cardiovasc Res       Date:  2020-01-01       Impact factor: 10.787

2.  Clinical characteristics and treatment of renal artery fibromuscular dysplasia with percutaneous transluminal angioplasty: a long-term follow-up study.

Authors:  Y K Yang; Y Zhang; X Meng; K Q Yang; X J Jiang; H Y Wu; H M Zhang; L Song; L P Wang; L G Gao; X L Zhou
Journal:  Clin Res Cardiol       Date:  2016-06-06       Impact factor: 5.460

Review 3.  Non-Atherosclerotic Vascular Disease in Women.

Authors:  Lee Joseph; Esther S H Kim
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-14

4.  European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection.

Authors:  David Adlam; Fernando Alfonso; Angela Maas; Christiaan Vrints
Journal:  Eur Heart J       Date:  2018-09-21       Impact factor: 29.983

5.  Association of Multifocal Fibromuscular Dysplasia in Elderly Patients With a More Benign Clinical Phenotype: Data From the US Registry for Fibromuscular Dysplasia.

Authors:  Imad Bagh; Jeffrey W Olin; James B Froehlich; Eva Kline-Rogers; Bruce Gray; Esther S H Kim; Aditya Sharma; Ido Weinberg; Bryan J Wells; Xiaokui Gu; Heather L Gornik
Journal:  JAMA Cardiol       Date:  2018-08-01       Impact factor: 14.676

6.  Low frequency of cervicocranial artery involvement in Japanese with renal artery fibromuscular dysplasia compared with that of Caucasians.

Authors:  Eikan Mishima; Shu Umezawa; Takehiro Suzuki; Miki Fujimura; Michiaki Abe; Junichiro Hashimoto; Takaaki Abe; Sadayoshi Ito
Journal:  Clin Exp Nephrol       Date:  2018-04-20       Impact factor: 2.801

7.  Loss-of-Function Mutations in YY1AP1 Lead to Grange Syndrome and a Fibromuscular Dysplasia-Like Vascular Disease.

Authors:  Dong-Chuan Guo; Xue-Yan Duan; Ellen S Regalado; Lauren Mellor-Crummey; Callie S Kwartler; Dong Kim; Kenneth Lieberman; Bert B A de Vries; Rolph Pfundt; Albert Schinzel; Dieter Kotzot; Xuetong Shen; Min-Lee Yang; Michael J Bamshad; Deborah A Nickerson; Heather L Gornik; Santhi K Ganesh; Alan C Braverman; Dorothy K Grange; Dianna M Milewicz
Journal:  Am J Hum Genet       Date:  2016-12-08       Impact factor: 11.025

8.  Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features.

Authors:  Santhi K Ganesh; Rachel Morissette; Zhi Xu; Florian Schoenhoff; Benjamin F Griswold; Jiandong Yang; Lan Tong; Min-Lee Yang; Kristina Hunker; Leslie Sloper; Shinie Kuo; Rafi Raza; Dianna M Milewicz; Clair A Francomano; Harry C Dietz; Jennifer Van Eyk; Nazli B McDonnell
Journal:  FASEB J       Date:  2014-04-14       Impact factor: 5.191

9.  Differences between the pediatric and adult presentation of fibromuscular dysplasia: results from the US Registry.

Authors:  Rebecca Green; Xiaokui Gu; Eva Kline-Rogers; James Froehlich; Pamela Mace; Bruce Gray; Barry Katzen; Jeffrey Olin; Heather L Gornik; Ann Marie Cahill; Kevin E Meyers
Journal:  Pediatr Nephrol       Date:  2015-11-02       Impact factor: 3.714

Review 10.  Coronary artery manifestations of fibromuscular dysplasia.

Authors:  Katherine C Michelis; Jeffrey W Olin; Daniella Kadian-Dodov; Valentina d'Escamard; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2014-09-09       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.